{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:57:03Z","timestamp":1782165423509,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.neulet.2022.136449","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:31:00Z","timestamp":1641814260000},"page":"136449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy of electroconvulsive therapy in Parkinson\u2019s disease: A clinical trial"],"prefix":"10.1016","volume":"772","author":[{"given":"Daryoush","family":"Afshari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Shakeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Khodamoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Nejad Shahrokh","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaza","family":"Rahkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Afshar Hezarkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neulet.2022.136449_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's Disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin North Am"},{"issue":"1016","key":"10.1016\/j.neulet.2022.136449_b0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/pgmj.2009.080432","article-title":"Medication management in people with Parkinson's disease during surgical admissions","volume":"86","author":"Derry","year":"2010","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.neulet.2022.136449_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neulet.2022.136449_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2019.01.015","article-title":"Fishing for Parkinson's Disease: A review of the literature","volume":"62","author":"\u00dcnal","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neulet.2022.136449_b0025","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/mds.1201","article-title":"Fatigue in Parkinson's disease: a nine-year follow-up","volume":"16","author":"Friedman","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neulet.2022.136449_b0030","first-page":"77","article-title":"The role of alpha-synuclein in Parkinson's disease","volume":"16","author":"Miklya","year":"2014","journal-title":"Neuropsychopharmacol Hung"},{"key":"10.1016\/j.neulet.2022.136449_b0035","first-page":"439","article-title":"Parkinson's disease: early diagnosis and management","volume":"36","author":"Stern","year":"1993","journal-title":"J Fam Pract"},{"issue":"1","key":"10.1016\/j.neulet.2022.136449_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0891988707311027","article-title":"Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature","volume":"21","author":"Wilkins","year":"2008","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"14","key":"10.1016\/j.neulet.2022.136449_b0045","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/mds.22233","article-title":"Anxiety rating scales in Parkinson's disease: critique and recommendations","volume":"23","author":"Leentjens","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.neulet.2022.136449_b0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.45.4.669","article-title":"Mortality and hallucinations in nursing home patients with advanced Parkinson's disease","volume":"45","author":"Goetz","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neulet.2022.136449_b0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00702-014-1212-4","article-title":"Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms","volume":"121","author":"Nishioka","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.neulet.2022.136449_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17425255.2018.1417387","article-title":"Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease","volume":"14","author":"Choi","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.neulet.2022.136449_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/YCT.0b013e31823c98c0","article-title":"Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study","volume":"28","author":"Pintor","year":"2012","journal-title":"J ECT"},{"key":"10.1016\/j.neulet.2022.136449_b0070","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/jnnp.2005.069849","article-title":"Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature","volume":"76","author":"Fregni","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4707","key":"10.1016\/j.neulet.2022.136449_b0075","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.4012304","article-title":"A guarded endorsement for shock therapy","volume":"228","author":"Holden","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neulet.2022.136449_b0080","article-title":"Miller's anesthesia e-book","author":"Miller","year":"2014","journal-title":"Elsevier Health Sciences"},{"key":"10.1016\/j.neulet.2022.136449_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YCT.0b013e3181c18a3d","article-title":"Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease","volume":"26","author":"Ueda","year":"2010","journal-title":"J ECT"},{"issue":"10","key":"10.1016\/j.neulet.2022.136449_b0090","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1590\/0004-282X20150131","article-title":"Electroconvulsive therapy in Parkinson's disease","volume":"73","author":"Calder\u00f3n-Fajardo","year":"2015","journal-title":"Arq Neuropsiquiatr"},{"issue":"1-2","key":"10.1016\/j.neulet.2022.136449_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jad.2010.09.023","article-title":"Electroconvulsive therapy for major depression within the Veterans Health Administration","volume":"130","author":"Pfeiffer","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neulet.2022.136449_b0100","first-page":"192","article-title":"Anaesthesia for electroconvulsive therapy","volume":"10","author":"Uppal","year":"2010","journal-title":"Cont Ed Anaesthesia Critical Care & Pain"},{"key":"10.1016\/j.neulet.2022.136449_b0105","unstructured":"B. Gedela, M.V. Lakshmi, K.R. Reddy, Association between Seizure Threshold and Seizure Duration in Psychotic Individuals Treated With Electro Convulsive Therapy: A Retrospective Study."},{"key":"10.1016\/j.neulet.2022.136449_b0110","article-title":"Response predictors in ECT: a discussion about seizure threshold","volume":"4","author":"Seshadri","year":"2011","journal-title":"BJMP"},{"key":"10.1016\/j.neulet.2022.136449_b0115","unstructured":"B.J. Sadock, V.A. Sadock, Kaplan & Sadock's comprehensive textbook of psychiatry, Vols. 1-2, lippincott Williams & Wilkins publishers, 2000."},{"issue":"4","key":"10.1016\/j.neulet.2022.136449_b0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.870060405","article-title":"Electroconvulsive therapy in Parkinson's disease and other movement disorders","volume":"6","author":"Faber","year":"1991","journal-title":"Mov Disord"},{"key":"10.1016\/j.neulet.2022.136449_b0125","doi-asserted-by":"crossref","unstructured":"J.E. Berg, Electroconvulsive treatment of a patient with Parkinson's disease and moderate depression, Ment Illn 3 (2011) e3.","DOI":"10.4081\/mi.2011.e3"},{"issue":"7","key":"10.1016\/j.neulet.2022.136449_b0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"4","key":"10.1016\/j.neulet.2022.136449_b0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1176\/jnp.15.4.407","article-title":"Electroconvulsive therapy in movement disorders: an update","volume":"15","author":"Kennedy","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.neulet.2022.136449_b0140","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.mehy.2009.06.053","article-title":"ECT for Parkinson's disease","volume":"73","author":"Popeo","year":"2009","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.neulet.2022.136449_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1589\/jpts.29.144","article-title":"Therapeutic effects of massage and electrotherapy on muscle tone, stiffness and muscle contraction following gastrocnemius muscle fatigue","volume":"29","author":"Wang","year":"2017","journal-title":"J Phys Ther Sci"},{"issue":"8","key":"10.1016\/j.neulet.2022.136449_b0150","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.neubiorev.2013.07.001","article-title":"A revised limbic system model for memory, emotion and behaviour","volume":"37","author":"Catani","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neulet.2022.136449_b0155","article-title":"Prolonged Post-electroconvulsive Therapy Delirium: An Unusual Presentation","volume":"10","author":"Khan","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.neulet.2022.136449_b0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/YCT.0000000000000142","article-title":"Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement","volume":"30","author":"Cumper","year":"2014","journal-title":"J ECT"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:42:47Z","timestamp":1759624967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394022000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":32,"alternative-id":["S0304394022000064"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136449","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of electroconvulsive therapy in Parkinson\u2019s disease: A clinical trial","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136449"}}